Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bedaquiline pharmacokinetics in adults with type 2 diabetes mellitus versus healthy volunteers
NL-OMON26912Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of bedaquiline in Tuberculosis (TB) (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Population pharmacokinetic model of bedaquiline and Pharmacokinetic parameters. Planned start Jun 2018; status: not yet recruiting.
02
Drugs
bedaquiline
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NL-OMON26912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26912.